Clinical Trials Logo

Filter by:
NCT ID: NCT02519140 Withdrawn - Gastric Cancer Clinical Trials

Assessing How the Viscosity of Submucosal Gel Injections Helps With Endoscopic Mucosal Resections

Start date: August 1, 2014
Phase: Phase 3
Study type: Interventional

This is a study to determine how the viscosity (thickness) of an FDA approved gel affects the ease in which endoscopic mucosal resections (EMR) can be performed.

NCT ID: NCT02517931 Withdrawn - Clinical trials for Postdural Puncture Headache

Sphenopalatine Ganglion Block for Postdural Puncture Headache in the Emergency Department

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

This study evaluates sphenopalatine ganglion block (SPGB) for the treatment of postdural puncture headache (PDPH) in the emergency department (ED). Half of the patients will receive a true nerve block with lidocaine and bupivacaine. The other half will receive a placebo nerve block.

NCT ID: NCT02517697 Withdrawn - Hypertension Clinical Trials

Oral Nitrite Trial for Hypertension and Metabolic Syndrome

ONPC
Start date: October 2020
Phase: Phase 2
Study type: Interventional

The objective of the study is to investigate effects of inorganic sodium nitrite on the cardiometabolic and hormonal disturbances observed in a targeted population of overweight/obese adults with metabolic syndrome and hypertension, at risk for insulin resistance and endothelial dysfunction.

NCT ID: NCT02517671 Withdrawn - Clinical trials for Cardiovascular Disease

Impact of Enhanced External Counterpulsation (EECP) on VO2 MAX

Start date: January 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the effects of 35 EECP sessions on cardiopulmonary training performance in healthy volunteers. Data from this study will be used to generate sample size and power calculations for feasibility of future EECP studies. The results of this study could provide evidence that can help active duty and Department of Defense beneficiaries optimize physical conditioning, endurance and overall health.

NCT ID: NCT02516436 Withdrawn - Opioid Dependence Clinical Trials

The Safety of Using Buprenorphine With Naloxone in a Buccal Film to Initiate Treatment of Opioid Dependent Subjects

Start date: n/a
Phase: Phase 3
Study type: Interventional

A randomized, double blind, active controlled study in approximately 40 opioid dependent subjects. Study duration is up to five days and includes a maximum of 3 days confinement in the clinic. Opioid dependent subjects who provide informed consent meet all entry criteria are eligible for enrollment into the study.

NCT ID: NCT02515513 Withdrawn - Pancreas Cancer Clinical Trials

The Role of Muscle Cachexia in Pancreatic Cancer

Start date: March 2016
Phase: N/A
Study type: Interventional

The relationship between myopenia, nutritional status, and long-term oncologic outcomes remains poorly characterized in patients with anatomically resectable pancreatic cancer (PC). The investigators want to look at muscle properties in pancreatic cancer patients to determine possible therapeutic options toward better nutritional status. Patients with benign right upper quadrant pathology will be utilized as controls for the study. The researchers hypothesize that improving cancer cachexia in PC will improve the quality of life and ultimately increase overall survival. The long term goal of is to identify areas of intervention to prevent and/or improve cachectic events in PC in order to significantly improve clinical outcomes. The first step in this long term goal is to fully characterize cachexia in the condition of PC. This research is to understand and modify the local response within skeletal muscle leading to a clinically relevant persistent wasting and to understand and interrupt the systemic stimulus produced by the tumor local environment resulting in these muscle specific mechanisms.

NCT ID: NCT02512029 Withdrawn - Clinical trials for Traumatic Brain Injury

18F-AV-1451 PET Imaging in TBI

Start date: October 2015
Phase: Phase 1
Study type: Interventional

This study will evaluate imaging characteristics of 18F-AV-1451 in subjects with subacute traumatic brain injury.

NCT ID: NCT02511613 Withdrawn - Clinical trials for Age-Related Macular Degeneration

Effect of Squalamine Lactate Ophthalmic Solution, 0.2% in Subjects With Neovascular Age-Related Macular Degeneration

Start date: July 2015
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate anatomical and functional effect of combination therapy of Squalamine Lactate Ophthalmic Solution, 0.2% administered twice daily with monthly ranibizumab intravitreal injections in patients with choroidal neovascularization due to AMD.

NCT ID: NCT02509182 Withdrawn - Hyperoxia Clinical Trials

The Effect of Decreasing the Inspired Oxygen Concentration on Post-Operative Oxygenation After Primary Lobectomy

Start date: December 2016
Phase: Phase 4
Study type: Interventional

The purpose of this study is to test the hypothesis that decreasing the inspired oxygen concentration during thoracic surgery requiring one lung ventilation will improve post-operative oxygenation.

NCT ID: NCT02507323 Withdrawn - Clinical trials for Cardiovascular Disease

Ticagrelor vs. Prasugrel Effects on Infarct Size

TIPRIS
Start date: February 2016
Phase: Phase 2
Study type: Interventional

This study has been designed as a randomized, double-blind trial to provide definitive evidence on the effects of ticagrelor and prasugrel on myocardial salvage in patients with anterior ST Segment Elevation Myocardial Infarction (STEMI) undergoing primary Percutaneous Coronary Intervention (PCI). This study will also measure the effects of ticagrelor vs. prasugrel on secondary endpoints listed above. This study design aims to test the hypothesis that ticagrelor will reduce myocardial infarct size as a proportion of the ischemic area at risk when compared to prasugrel.